Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $3.3 million.

  • Nexgel's Total Current Liabilities rose 853.02% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 853.02%. This contributed to the annual value of $2.5 million for FY2024, which is 309.93% down from last year.
  • Nexgel's Total Current Liabilities amounted to $3.3 million in Q3 2025, which was up 853.02% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Nexgel's Total Current Liabilities ranged from a high of $3.3 million in Q3 2025 and a low of $859000.0 during Q4 2022
  • Moreover, its 5-year median value for Total Current Liabilities was $2.4 million (2021), whereas its average is $2.2 million.
  • In the last 5 years, Nexgel's Total Current Liabilities plummeted by 7025.62% in 2022 and then skyrocketed by 19674.04% in 2023.
  • Nexgel's Total Current Liabilities (Quarter) stood at $2.9 million in 2021, then crashed by 70.26% to $859000.0 in 2022, then soared by 196.74% to $2.5 million in 2023, then decreased by 3.1% to $2.5 million in 2024, then surged by 33.93% to $3.3 million in 2025.
  • Its Total Current Liabilities was $3.3 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.5 million in Q1 2025.